Becton, Dickinson and Company BDX Medical — Segment, Expenditure, Addition to Long-Lived Assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Becton, Dickinson and Company in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The official record: Becton, Dickinson and Company’s 10-K, filed November 25, 2025, on SEC EDGAR. View the filing →
Ask your AI about Becton, Dickinson and Company's medical — segment, expenditure, addition to long-lived assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Becton, Dickinson and Company's medical — segment, expenditure, addition to long-lived assets?
- Becton, Dickinson and Company (BDX) reported medical — segment, expenditure, addition to long-lived assets of $117.25M in Q3 2025.
- How has Becton, Dickinson and Company's medical — segment, expenditure, addition to long-lived assets changed year-over-year?
- Becton, Dickinson and Company's medical — segment, expenditure, addition to long-lived assets increased by 7.1% year-over-year, from $109.5M to $117.25M.
- What is the long-term trend for Becton, Dickinson and Company's medical — segment, expenditure, addition to long-lived assets?
- Over 4 years (2021 to 2025), Becton, Dickinson and Company's medical — segment, expenditure, addition to long-lived assets has grown at a -10.8% compound annual growth rate (CAGR), from $740M to $469M.
- What does medical — segment, expenditure, addition to long-lived assets mean?
- This represents the capital expenditures dedicated to acquiring or upgrading long-term physical assets, such as manufacturing equipment or facilities, specifically for the medical segment. It reflects the company's investment in maintaining or expanding its production capacity for medical devices.